Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study

There is an increased demand for efficient biomarkers for the diagnosis of non-small cell lung cancer (NSCLC). This study aimed to evaluate plasma levels of TrxR activity in a large population to confirm its validity and efficacy in NSCLC diagnosis. Blood samples were obtained from 1922 participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Suofu, Chen, Xiaofeng, Yao, Yi, Li, Yueqin, Sun, Ruoxuan, Zeng, Huihui, Shu, Yongqian, Yin, Hanwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389956/
https://www.ncbi.nlm.nih.gov/pubmed/30804354
http://dx.doi.org/10.1038/s41598-018-38153-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389956/
https://www.ncbi.nlm.nih.gov/pubmed/30804354
http://dx.doi.org/10.1038/s41598-018-38153-7

Ejemplares similares